HEP B (RECOMBIVAX) VACCINE

VACCINE USAGE: RECOMBIVAX HB is a vaccine indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in individuals of all ages.

RECOMBIVAX HB DIALYSIS FORMULATION is approved for use in predialysis and dialysis patients 18 years of age and older.

VACCINE DOSAGE:

  • Persons from birth through 19 years of age: A series of 3 doses (0.5 mL each) given on a 0-, 1-, and 6-month schedule.
  • Adolescents 11 through 15 years of age: A series of either 3 doses (0.5 mL each) given on a 0-, 1-, and 6-month schedule or a series of 2 doses (1.0 mL) on a 0- and 4- to 6-month schedule).
  • Persons 20 years of age and older: A series of 3 doses (1.0 mL each) given on a 0-, 1-, and 6-month schedule.

RECOMBIVAX HB DIALYSIS FORMULATION:<

  • Adults on predialysis or dialysis: A series of 3 doses (1.0 mL each) given on a 0-, 1-, and 6-month schedule.

VACCINE INGEDIENTS: yeast protein, soy peptone, dextrose, amino acids, mineral salts, potassium aluminum sulfate, amorphous aluminum hydroxyphosphate sulfate, formaldehyde.

ADVERSE VACCINE REACTIONS: fatigue, weakness, high fever, nausea, diarrhea, pharyngitis, upper respiratory infection, sweating, chills, diminished appetite, rhinitis, influenza, cough, vertigo/ dizziness, paresthesia, pruritus, rash, angioedema, myalgia, back pain, lymphadenopathy, insomnia, earaches, dysuria, hypotension, elevation of liver enzymes, constipation, Guillain- Barre syndrome, multiple sclerosis, seizures, febrile seizures, herpes zoster, encephalitis, eczema, arthritis, extreme pain, lupus-like syndrome.